Replies to post #2575 on BioCurex, Inc.(fka BOCX)

[Kag]

We know that presently there are many companies who are in the process of developing cancer detection tests. The important question is, how many of them are already partnered with the largest diagnostics company in the world? Suprisingly, a search of Abbott's past few years of press releases show that there are almost none. Possibly one or two that have to do with specific cancer detection tests. The truth is that any new cancer detection test, in order to be successful and produce lots of revenue, will have to be run on one of the automated analyzers like Abbott's architect system. And it sure appears that BOCX's business model is right on track. BOCX's RECAF serum technology was licensed early to Abbott to be developed by Abbott and implemented into Abbott's Architect system. kag